Infliximab Biosimilar Utilization in a Large Pediatric Learning Health System

Ross M. Maltz; Shehzad A. Saeed; Jeremy Adler

doi:10.3390/children12050656

Infliximab Biosimilar Utilization in a Large Pediatric Learning Health System

Ross M. Maltz
, Shehzad A. Saeed
, Jeremy Adler

Pediatrics

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	656
Journal	Children
Volume	12
Issue number	5
DOIs	https://doi.org/10.3390/children12050656
State	Published - May 2025

ASJC Scopus Subject Areas

Pediatrics, Perinatology, and Child Health

Keywords

ImproveCareNow
anti-TNF
inflammatory bowel disease

Access to Document

10.3390/children12050656

Cite this

@article{7010221a3fa24fa3b5e2af313f0db5c5,

title = "Infliximab Biosimilar Utilization in a Large Pediatric Learning Health System",

keywords = "ImproveCareNow, anti-TNF, inflammatory bowel disease",

author = "Maltz, \{Ross M.\} and Saeed, \{Shehzad A.\} and Jeremy Adler",

note = "Publisher Copyright: {\textcopyright} 2025 by the authors.",

year = "2025",

month = may,

doi = "10.3390/children12050656",

language = "English",

volume = "12",

journal = "Children",

issn = "2227-9067",

number = "5",

}

TY - JOUR

T1 - Infliximab Biosimilar Utilization in a Large Pediatric Learning Health System

AU - Maltz, Ross M.

AU - Saeed, Shehzad A.

AU - Adler, Jeremy

PY - 2025/5

Y1 - 2025/5

KW - ImproveCareNow

KW - anti-TNF

KW - inflammatory bowel disease

UR - https://www.scopus.com/pages/publications/105006453205

UR - https://www.scopus.com/pages/publications/105006453205#tab=citedBy

U2 - 10.3390/children12050656

DO - 10.3390/children12050656

M3 - Article

C2 - 40426835

AN - SCOPUS:105006453205

SN - 2227-9067

VL - 12

JO - Children

JF - Children

IS - 5

M1 - 656

ER -

Infliximab Biosimilar Utilization in a Large Pediatric Learning Health System

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Cite this